Results 191 to 200 of about 19,469,886 (406)

Identification and Validation of Antidepressant Small Molecules Using Bioinformatics and Mouse Depression Models

Drug Design, Development and Therapy
Yajun Qiao,1– 4,* Xingfang Zhang,2,5,6,* Hanxi Chen,2,5 Xinxin Liang,1– 4 Juan Guo,1,3 Qiannan Wang,2,5 Yi Ding,6 Lixin Wei,2,5 Hongtao Bi,2,4,5 Tingting Gao1,3 1School of Psychology, Chengdu Medical College, Chengdu, Sichuan, People’s ...
Qiao Y, Zhang X, Chen H, Liang X, Guo J, Wang Q, Ding Y, Wei L, Bi H, Gao T   +9 more
doaj  

Safety evaluation of jagua (genipin-glycine) blue as a food additive. [PDF]

EFSA J
EFSA Panel on Food Additives and Flavourings (FAF), Castle L, Andreassen M, Aquilina G, Bastos ML, Boon P, Fallico B, FitzGerald R, Frutos Fernandez MJ, Grasl-Kraupp B, Gundert-Remy U, Gürtler R, Houdeau E, Kurek M, Louro H, Morales P, Passamonti S, Barat Baviera JM, Degen G, Gott D, Leblanc JC, Moldeus P, Waalkens-Berendsen I, Wölfle D, Civitella C, Mech A, Medrano-Padial C, Tard A, Zakidou P, Ruggeri L.   +29 more
europepmc   +1 more source

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Omalizumab in Patients With Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite H1 Antihistamine Therapy

Novartis
openalex   +1 more source

Feasibility and Tolerability of Performing Portable MRI for Neurological Disorders in an Outpatient Neurology Clinic: A Prospective Cohort

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Accessing brain magnetic resonance imaging (MRI) can be challenging, especially for underserved patients, which may lead to disparities in neurological diagnosis. Method This mixed‐methods study enrolled adults with one of four neurological disorders: mild cognitive impairment or dementia of the Alzheimer type, multiple sclerosis ...
Maya L. Mastick, Nomin Enkhtsetseg, Joseph Sadok, Matheus Mochetti, Annabel Sorby Adams, Jennifer Guo, Cristina Trapaga Hacker, Isabella Gomez Hjerthen, Seungwon Lee, Siddharth Satish, Andrew S. Ham, Justin Hill, Denis Balaban, Kevin Kyle, Rebecca L. Gillani, Marcelo Matiello, Aleksandar Videnovic, Eric C. Klawiter, W. Taylor Kimberly, Farrah J. Mateen   +19 more
wiley   +1 more source

Safety evaluation of a fungal beta-glucanase. [PDF]

Toxicol Rep
Jondhale D, Harris C, Ladics GS.
europepmc   +1 more source

Safety Risk Evaluation by Vessel Type and Accident Category in an Archipelagic State: An Empirical Data Analysis from Indonesia

Sunardi, Aleik Nurwahyudi, Eko Sulkhany, Arief Setyanto, Heri Supomo, Sapto P. Kertorahardjo   +5 more
openalex   +1 more source

Multilingual Blending: Large Language Model Safety Alignment Evaluation with Language Mixture [PDF]

Jiayang Song, Yuheng Huang, Zhehua Zhou, Lei Ma   +3 more
openalex   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang, Sandra Blitz, Nick Bansback, Michael Law, Mark Harrison   +4 more
wiley   +1 more source

Safety evaluation of pectin-rich extract derived from Coffea arabica as food additive. [PDF]

EFSA J
EFSA Panel on Food Additives and Flavourings (FAF), Castle L, Andreassen M, Aquilina G, Bastos ML, Boon P, Fallico B, FitzGerald R, Frutos Fernandez MJ, Grasl-Kraupp B, Gundert-Remy U, Gürtler R, Houdeau E, Kurek M, Louro H, Morales P, Passamonti S, Barat Baviera JM, Degen G, Gott D, Leblanc JC, Moldeus P, Waalkens-Berendsen I, Wölfle D, Mech A, Tard A, Zakidou P, Ruggeri L.   +27 more
europepmc   +1 more source

Systematic Safety Information Gaps in AI-Generated Melanoma Therapy Information: An Exploratory Multi-Platform Evaluation

Jennifer M. Hinkel, Shivani Modi, Cory Kidd   +2 more
openalex   +1 more source